SUNPHARMA:NSE Sun Pharmaceutical Industries Limited

INR 1,604.15 6.05 0.378575
Icon

Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 1,604.15

+6.05 (+0.38)%

INR 3,736.24B

2.53M

N/A

INR 1025.00 (-36.10%)

Icon

SUNPHARMA:NSE

Sun Pharmaceutical Industries Limited (INR)
COMMON STOCK | NSE
INR 1,604.15
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

INR 3,736.24B

INR 1025.00 (-36.10%)

INR 1,604.15

Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock Forecast

INR 1,412.33
(-11.96%)

Based on the Sun Pharmaceutical Industries Limited stock forecast from 4 analysts, the average analyst target price for Sun Pharmaceutical Industries Limited is INR 1,412.33 over the next 12 months. Sun Pharmaceutical Industries Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sun Pharmaceutical Industries Limited is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Sun Pharmaceutical Industries Limited’s stock price was INR 1,604.15. Sun Pharmaceutical Industries Limited’s stock price has changed by +3.54% over the past week, +1.35% over the past month and +63.11% over the last year.

No recent analyst target price found for Sun Pharmaceutical Industries Limited
No recent average analyst rating found for Sun Pharmaceutical Industries Limited

Company Overview Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, i...Read More

https://www.sunpharma.com

Sun House, Mumbai, India, 400063

41,000

March

INR

India

Adjusted Closing Price for Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE)

Loading...

Unadjusted Closing Price for Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE)

Loading...

Share Trading Volume for Sun Pharmaceutical Industries Limited Shares

Loading...

Compare Performance of Sun Pharmaceutical Industries Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SUNPHARMA:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sun Pharmaceutical Industries Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DRREDDY:NSE
Dr. Reddy's Laboratories Limit.. -87.75 (-1.43%) INR1,029.83B 19.74 11.55

ETFs Containing SUNPHARMA

Symbol Name SUNPHARMA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock

Based on ratings from 4 analysts Sun Pharmaceutical Industries Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, sell and 1 hold ratings.

SUNPHARMA:NSE stock's dividend yield is 0.80%. Our analysis grades SUNPHARMA:NSE stock's dividend yield at D. This means that SUNPHARMA:NSE stock's dividend yield is above 64% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this SUNPHARMA:NSE may be a average dividend stock for its sector.

Based on targets from 4 analysts, the average taret price for SUNPHARMA:NSE is INR 1,412.33 over the next 12 months. The maximum analyst target price is INR 1827 while the minimum anlayst target price is INR 1200.

SUNPHARMA:NSE stock's Price/Earning ratio is 41.91. Our analysis grades SUNPHARMA:NSE stock's Price / Earning ratio at F. This means that SUNPHARMA:NSE stock's Price/Earning ratio is above 57.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this SUNPHARMA:NSE may be a overvalued for its sector.

The last closing price of SUNPHARMA:NSE's stock was INR 1,604.15.

The most recent market capitalization for SUNPHARMA:NSE is INR 3,736.24B.

Based on targets from 4 analysts, the average taret price for SUNPHARMA:NSE is projected at INR 1,412.33 over the next 12 months. This means that SUNPHARMA:NSE's stock price may go down by -11.96% over the next 12 months.

We can't find any ETFs which contains Sun Pharmaceutical Industries Limited's stock.

As per our most recent records Sun Pharmaceutical Industries Limited has 41,000 Employees.

Sun Pharmaceutical Industries Limited's registered address is Sun House, Mumbai, India, 400063. You can get more information about it from Sun Pharmaceutical Industries Limited's website at https://www.sunpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...